2′-O-(2-Methoxyethyl)guanosine (2'-O-MOE-rG), a modified nucleoside, can be enzymatically converted from 2′-O-(2-methoxyethyl)-2,6-diaminopurine riboside by adenosine deaminase. However, this compound is not readily phosphorylated by cytosolic nucleoside kinases, and it cannot be incorporated into cellular DNA or RNA.
dMCL1-2 is a potent and selective myeloid leukemia 1 (MCL1) degrading agent based on PROTAC, which binds to MCL1 with a KD of 30 nM. dmcl-2 activates the apoptosis mechanism by degrading MCL1.This compound is unstable in powder form and other related salt forms are recommended.
ERK1 2 inhibitor 1 is a potent, orally bioavailable ERK1 2 inhibitor, showing 60% inhibition at 1 nM and an IC50 of 3.0 nM against ERK1 and ERK2, respectively.